Product Program year 2024 Source: CMS Open Payments

Senza

Device Spinal Cord Stimulator

PDI 00813426020015

Open in the dashboard

General payments

$2,569,332

58,853 payments

Research payments

$83,618

18 payments

Through program year 2024, $2,569,332 in general payments and $83,618 in research payments were reported against Senza (Spinal Cord Stimulator).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2024 General $1,227,733 29,623
2023 General $1,188,824 28,258
2022 General $133,655 706
2022 Research $16,451 11
2021 General $19,120 266
2021 Research $67,168 7

Breakdown

Who paid General payments · program years 2021–2024
  1. Nevro Corp. $2,569,332 58,853 payments
Top recipients General payments · program year 2024
  1. Douglas Beall Diagnostic Radiology · Edmond, OK $6,365 <1% · 49 payments
  2. Alexander Escobar Pain Medicine · Toledo, OH $5,921 <1% · 54 payments
  3. Michael Dorsi Neurological Surgery · Thousand Oaks, CA $5,201 <1% · 63 payments
  4. Brett Himmelwright Orthopaedic Surgery · Camp Hill, PA $4,294 <1% · 19 payments
  5. Timothy Ratino Interventional Pain Medicine · Fort Worth, TX $4,075 <1% · 46 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Pain Medicine Anesthesiology $181,963 15% · 905 practitioners
  2. Interventional Pain Medicine Pain Medicine $149,193 12% · 722 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $101,641 8% · 1,134 practitioners
  4. Physician Assistant $84,898 7% · 933 practitioners
  5. Physical Medicine & Rehabilitation $70,808 6% · 402 practitioners

The top 5 of 125 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Texas $173,959 14% · 1,320 recipients
  2. Florida $95,008 8% · 1,038 recipients
  3. California $93,115 8% · 723 recipients
  4. Michigan $70,923 6% · 424 recipients
  5. New York $66,621 5% · 530 recipients

The top 5 of 53 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

58,853 general · 18 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record